Our study reveals a previously unrecognized role for SMOC2 in cancer progression by upregulating EMT features of RCC cells through integrin pathways and suggests that such regulation of cellular phenotype can lead to an increase in mitogenic and migratory behavior. Here, SMOC2 is linked to renal cell carcinoma.